[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Active Pharmaceutical Ingredient Market Survey and Trend Research 2018

December 2017 | 172 pages | ID: GE43B460DF7EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Teva, Novartis, Pfizer, Johnson & Johnson, North China Pharmaceutical Group, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group, Cipla, Tian Yao, Lupin, North East Pharmaceutical, Albemarle, Shandong Lukang Pharmaceutical, Jiangsu Hengrui Medicine, Bachem etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Active Pharmaceutical Ingredient Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Teva (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Novartis (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Pfizer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 North China Pharmaceutical Group (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 North China Pharmaceutical Group (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Dr. Reddy’s Laboratories (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Roche (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Aurobindo pharma (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Sun Pharmaceutical Industries (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Boehringer Ingelheim GmbH (Company Overview, Sales Data etc.)
4.12 Bayer (Company Overview, Sales Data etc.)
4.13 BASF (Company Overview, Sales Data etc.)
4.14 DSM (Company Overview, Sales Data etc.)
4.15 Zhejiang Medicine (Company Overview, Sales Data etc.)
4.16 Biocon (Company Overview, Sales Data etc.)
4.17 Johnson Matthey (Company Overview, Sales Data etc.)
4.18 Hisun Pharmacy (Company Overview, Sales Data etc.)
4.19 Cambrex (Company Overview, Sales Data etc.)
4.20 Shandong Xinhua Pharmaceutical (Company Overview, Sales Data etc.)
4.21 Lonza group (Company Overview, Sales Data etc.)
4.22 Huahai Pharmaceutical (Company Overview, Sales Data etc.)
4.23 Haerbin Pharmaceutical Group (Company Overview, Sales Data etc.)
4.24 Cipla (Company Overview, Sales Data etc.)
4.25 Tian Yao (Company Overview, Sales Data etc.)
4.26 Lupin (Company Overview, Sales Data etc.)
4.27 North East Pharmaceutical (Company Overview, Sales Data etc.)
4.28 Albemarle (Company Overview, Sales Data etc.)
4.29 Shandong Lukang Pharmaceutical (Company Overview, Sales Data etc.)
4.30 Jiangsu Hengrui Medicine (Company Overview, Sales Data etc.)
4.31 Bachem (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Active Pharmaceutical Ingredient Market 2012-2017, by Type, in Volume
Table Global Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Type, in USD Million
Table Global Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Type, in Volume
Table Teva Overview List
Table Active Pharmaceutical Ingredient Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Active Pharmaceutical Ingredient Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Active Pharmaceutical Ingredient Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Active Pharmaceutical Ingredient Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table North China Pharmaceutical Group Overview List
Table Active Pharmaceutical Ingredient Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table North China Pharmaceutical Group Overview List
Table Active Pharmaceutical Ingredient Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Overview List
Table Active Pharmaceutical Ingredient Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Active Pharmaceutical Ingredient Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aurobindo pharma Overview List
Table Active Pharmaceutical Ingredient Business Operation of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Industries Overview List
Table Active Pharmaceutical Ingredient Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Active Pharmaceutical Ingredient Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Active Pharmaceutical Ingredient Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BASF Overview List
Table Active Pharmaceutical Ingredient Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DSM Overview List
Table Active Pharmaceutical Ingredient Business Operation of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zhejiang Medicine Overview List
Table Active Pharmaceutical Ingredient Business Operation of Zhejiang Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Active Pharmaceutical Ingredient Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson Matthey Overview List
Table Active Pharmaceutical Ingredient Business Operation of Johnson Matthey (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hisun Pharmacy Overview List
Table Active Pharmaceutical Ingredient Business Operation of Hisun Pharmacy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cambrex Overview List
Table Active Pharmaceutical Ingredient Business Operation of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shandong Xinhua Pharmaceutical Overview List
Table Active Pharmaceutical Ingredient Business Operation of Shandong Xinhua Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lonza group Overview List
Table Active Pharmaceutical Ingredient Business Operation of Lonza group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Huahai Pharmaceutical Overview List
Table Active Pharmaceutical Ingredient Business Operation of Huahai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Haerbin Pharmaceutical Group Overview List
Table Active Pharmaceutical Ingredient Business Operation of Haerbin Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Active Pharmaceutical Ingredient Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tian Yao Overview List
Table Active Pharmaceutical Ingredient Business Operation of Tian Yao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lupin Overview List
Table Active Pharmaceutical Ingredient Business Operation of Lupin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table North East Pharmaceutical Overview List
Table Active Pharmaceutical Ingredient Business Operation of North East Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Albemarle Overview List
Table Active Pharmaceutical Ingredient Business Operation of Albemarle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shandong Lukang Pharmaceutical Overview List
Table Active Pharmaceutical Ingredient Business Operation of Shandong Lukang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiangsu Hengrui Medicine Overview List
Table Active Pharmaceutical Ingredient Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bachem Overview List
Table Active Pharmaceutical Ingredient Business Operation of Bachem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Active Pharmaceutical Ingredient Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Active Pharmaceutical Ingredient Sales Revenue Share, by Companies, in USD Million
Table Global Active Pharmaceutical Ingredient Sales Volume 2012-2017, by Companies, in Volume
Table Global Active Pharmaceutical Ingredient Sales Revenue Share, by Companies in 2017, in Volume
Table Active Pharmaceutical Ingredient Demand 2012-2017, by Application, in USD Million
Table Active Pharmaceutical Ingredient Demand 2012-2017, by Application, in Volume
Table Active Pharmaceutical Ingredient Demand Forecast 2018-2023, by Application, in USD Million
Table Active Pharmaceutical Ingredient Demand Forecast 2018-2023, by Application, in Volume
Table Global Active Pharmaceutical Ingredient Market 2012-2017, by Region, in USD Million
Table Global Active Pharmaceutical Ingredient Market 2012-2017, by Region, in Volume
Table Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Region, in USD Million
Table Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Active Pharmaceutical Ingredient Industry Chain Structure
Figure Global Active Pharmaceutical Ingredient Market Growth 2012-2017, by Type, in USD Million
Figure Global Active Pharmaceutical Ingredient Market Growth 2012-2017, by Type, in Volume
Figure Global Active Pharmaceutical Ingredient Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Active Pharmaceutical Ingredient Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications